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Summary: In lifestyle intervention trials, where the goal is to change a participant’s weight or modify their eating
behavior, self-reported diet is a longitudinal outcome variable that is subject to measurement error. We propose a
statistical framework for correcting for measurement error in longitudinal self-reported dietary data by combining
intervention data with auxiliary data from an external biomarker validation study where both self-reported and
recovery biomarkers of dietary intake are available. In this setting, dietary intake measured without error in the
intervention trial is missing data and multiple imputation is used to fill in the missing measurements. Since most
validation studies are cross-sectional, they do not contain information on whether the nature of the measurement
error changes over time or differs between treatment and control groups. We use sensitivity analyses to address the
influence of these unverifiable assumptions involving the measurement error process and how they affect inferences
regarding the effect of treatment. We apply our methods to self-reported sodium intake from the PREMIER study,
a multi-component lifestyle intervention trial.
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1. Introduction
Lifestyle intervention studies—which aim to change a participant’s weight or eating behavior—
often use self-reported measures of diet, but obtaining accurate measurement of diet and its
change over time is a major challenge due to measurement error. Measurement error in
intervention studies can result in biased estimates of the treatment effect as well as reduced
power to detect treatment effects (Forster et al. 1990). Little attention has been paid to
correcting for measurement error when an outcome is measured with error, partly due to
the fact that when outcomes measured with error are unbiased, parameters for means can
still be estimated without error, although with less power (Carroll et al. 2006). In this paper
we focus on intervention studies where longitudinal trends in an outcome are of interest.
In these settings—particularly in lifestyle interventions—outcomes measured with error are
not unbiased and the process that gives rise to measurement error may change—resulting in
more or less bias—as a function of time and as a result of the intervention.
Dietary intake in lifestyle interventions is often measured using a 24-hour dietary recall in
which the previous day’s intake is reported. Estimates from 24-hour recalls are subject to
measurement error, primarily due to memory limitations and poor quantification of portion
sizes, as well as the fact that the selected days of intake may not be representative of a
participant’s usual intake (Willet 2013, Chapter 4).
Longitudinal dietary intervention studies involve repeated dietary assessments over time
and produce measurement error issues in addition to those encountered in descriptive studies.
Participants may modify their reporting behavior to appear compliant with the dietary
recommendations of the intervention (Espeland et al. 2001), or they may attempt to reduce
reporting time and reporting difficulty by omitting items or by erroneously reporting foods
that are easier to measure or describe (Buzzard et al. 1996). Alternatively, their accuracy
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may improve due to training in portion size assessment and a more general awareness of
their dietary intake (Natarajan et al. 2010, Espeland et al. 2001).
Dietary validation studies measure—on the same set of participants—both self-reported
diet as well as unbiased estimates of dietary intake using urinary biomarkers, which require a
participant to collect their urine for 24 hours. Currently, urinary biomarkers exist for protein,
potassium, and sodium intake.
With a validation study, one can model the relationship between the self-reported variable
measured with error and true intake. Then, true intake in the intervention study can be
imputed so that dietary intake estimands of interest can be based on measurement error-
corrected values. This approach of using external validation samples and treating variables
measured without error as missing data has been used in a number of applications, see for
example, Shardell et al. (2010), Schenker et al. (2010) and Guo et al. (2012).
In this paper, we extend missing data approaches for measurement error correction to in-
tervention studies with longitudinal outcomes. External dietary validation studies are almost
always cross-sectional, meaning that information on changes in measurement error over time
and in response to treatment is not available. As a result, identification of parameters in our
measurement error correction model requires parameter restrictions based on unverifiable
assumptions regarding the measurement error process and its change over time and in
response to treatment. We describe the use of sensitivity analyses to address the influence
of these unverifiable assumptions on inferences.
2. Scientific background and data sources
The PREMIER Study (Appel et al. 2003), a randomized trial designed to determine the
effects of lifestyle interventions on blood pressure among free-living individuals, enrolled 810
adults with above-optimal blood pressure who were not taking antihypertensive medications.
Participants were randomly assigned to one of three intervention groups: Established, Estab-
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lished Plus DASH, and an Advice-Only comparison group. Participants in the Established
group received instruction and counseling over 6 months to modify their diet—including
calorie and sodium consumption—and increase their physical activity. Those in the Estab-
lished Plus DASH group had the same intervention as the Established group, and were also
taught to follow a diet rich in fruits, vegetables, and low fat dairy products. Participants
in both active intervention conditions received 18 face-to-face intervention contacts during
the initial 6 months of the study and were counseled to reduce sodium intake to less than
2300 mg/day. Participants in the Advice-Only condition received lifestyle advice during two
30-minute individual sessions, one at baseline and one at 6-months.
Self-reported dietary intake in PREMIER—including sodium intake, our outcome of interest—
was measured using two unannounced, non-consecutive, 24-hour recalls conducted by tele-
phone on one weekday and one weekend day at baseline and at 6- and 18-months. We
combine the Established and the Established Plus DASH groups into a single treatment
condition since changes in sodium intake were similar in the two groups (Appel et al. 2003).
We compare this single treatment condition to the Advice-Only condition.
PREMIER was the rare lifestyle intervention that collected 24-hour urine samples on all
participants at each time point. We will revisit these biomarker data in Section 7 when
we compare the results of our measurement error correction methods to an analysis that
uses PREMIER 24-hour urinary sodium. For now, we will ignore the PREMIER 24-hour
urine samples and treat the PREMIER study as a “typical” lifestyle intervention where only
self-reported dietary data are collected.
To correct for measurement error in PREMIER self-reported sodium intake, we use data
from the Observing Protein and Energy Nutrition (OPEN) validation study (Subar et al.
2003). OPEN participants were 484 men and women aged 40-69 years. In addition to two 24-
hour recalls, participants were assessed for sodium, potassium, and nitrogen intake via two 24-
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hour urine collections. As only 86% of sodium intake appears in urine, urinary sodium values
were divided by 0.86 to convert them to dietary sodium values (Willet 2013, Chapter 8).
Table 1 presents demographic characteristics and sodium intake in PREMIER at baseline
and in OPEN. Participant ages in the two studies are similar, although PREMIER partici-
pants have higher BMI, slightly lower self-reported sodium intake, and a smaller percentage
of men. A small proportion of outliers were removed from both samples using criteria detailed
in Web Appendix A.
[Table 1 about here.]
We estimate the treatment effect in PREMIER by comparing the change in (log-transformed)
sodium intake from baseline to the end of the intervention phase (6-months) between the
Treatment and Advice-Only conditions. Let Zj be the true value of the outcome we wish to
measure at time j, j = 0, . . . ,m where baseline is j = 0. Let Yj be Zj measured with error
and D an indicator as to whether a participant has been randomized to the intervention
group (D = 1) or the control group (D = 0). The treatment effect is,
ψ = {E(Z1|D = 1)− E(Z0|D = 1)} − {E(Z1|D = 0)− E(Z0|D = 0)}. (1)
When ψ < 0, reduction in mean log sodium intake is greater in the treatment group than
the control group (or less commonly, increase in intake is less in the treatment group than
the control group). Significance of the treatment effect is based on a two-sample t-test of the
difference in change scores between treatment and control groups. We report the effect size:
the estimate of the treatment effect in (1) divided by the pooled standard deviation of the
change scores.
An analysis of the self-reported PREMIER data produced a significant treatment effect
where the effect size at 6-months was -0.49 (p<.0001). Our goal is to estimate the treatment
effect in (1) using measurement error corrected sodium intake.
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3. Definitions
We define how measurement error correction models can change over time and with respect
to treatment. Our measurement error correction models condition on the variable measured
with error so we refer to them as calibration models to highlight connections with regression
calibration (Carroll et al. 2006) in which a similar approach is used. Let X represent
background covariates measured at baseline.
Definition 1: The calibration model is treatment invariant if f(Zj | Yj,X, D = 1) =
f(Zj | Yj,X, D = 0), for j > 0. That is, the parameters of the calibration model do
not change in response to treatment and are the same in both treatment and control
groups. We assume calibration model invariance with respect to treatment holds at
baseline (j = 0) because treatment has not started yet.
Definition 2: The calibration model is time invariant if
f(Zj |Yj,X, D = d) = f(Zk |Yk,X, D = d), for all j 6= k, where j and k are two different
time points. Here, within a treatment condition, the parameters of the calibration model
will be the same across all time points.
Definition 3: The calibration model is treatment and time invariant if
f(Zj | Yj,X, D = 1) = f(Zk | Yk,X, D = 0), for all j, k.
Definition 4: If the parameters of the calibration model in the intervention data at time
j for treatment group d are the same as the parameters of the calibration model using
external validation data, then the parameters from the calibration model using external
validation data are transportable to the calibration model for that treatment-by-time
combination. Let S denote whether a participant is in the lifestyle intervention (S = `)
or validation study (S = v). Under calibration model transportability, the following
holds: f(Zj | Yj,X, D = d, S = `) = f(Z0 | Y0,X, S = v).
Our definition of calibration model transportability assumes the external validation study
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is cross-sectional (corresponding to the baseline time point in the intervention study) and ob-
servational (no treatment conditions) and that transportability can apply at some treatment-
by-time combinations but not others. When the calibration model is treatment and time
invariant, transportability at any treatment-by-time combination implies transportability at
all treatment-by-time combinations. In Web Appendix B, we show that our definition of
calibration model transportability implies that selection into the trial or validation study
does not depend on unobserved Z after conditioning on observed characteristics Y and X,
which is a plausible selection mechanism our setting where study inclusion criteria are based
on observed characteristics.
4. Methods
The top half of Table 2 represents data from PREMIER where the outcomes Y0 and Y1
represent self-reported sodium intake via 24-hour recall measured at baseline and 6-months,
respectively.
[Table 2 about here.]
The bottom half of Table 2 represents data from OPEN which contains Y0, self-reported
sodium, but also contains the variables W01 and W02 which are the two replicate urinary
sodium samples taken at baseline in OPEN. The shaded cells in Table 2 represent values
that are observed, the white cells are values that are missing. Urinary sodium is an unbiased
measure of true sodium intake but is also subject to error. In Section 4.1 we describe use of
W01 and W02 in OPEN to correct for measurement error in urinary sodium intake in order
to obtain true sodium intake at baseline Z0. The column labeled X in Table 2 represents
background covariates available on all participants in both studies. Here we condition on sex
and (log) BMI in all our models as there is some evidence that these variables are associated
with measurement error (Willet 2013, Chapter 4).
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Since OPEN—like most external validation studies—is cross-sectional, we assume that its
data correspond to baseline values Y0 and Z0 and that all OPEN participants belong to the
control condition. Values of Z1 in Table 2 are completely unobserved for all participants,
both those in the intervention study and those in the validation study. We thus have no
information on the relationship between Y1 and Z1.
The joint distribution of Y and Z, conditional on X and D in PREMIER, can be written
as f(Z1, Z0, Y1, Y0 |X, D, θ), where θ is a finite-dimensional parameter vector. While the focus
of our inference is on Z, it is necessary to also model Y due to missing values in Y which we
assume are ignorable.
The joint distribution can be further decomposed into observed and missing components.
Suppressing D and the parameters θ we have:
f(Z1, Y1, Z0, Y0 |X) = f(Z1 | Y1, Z0, Y0,X)f(Z0 | Y1, Y0,X)f(Y1, Y0 |X). (2)
We assume multivariate normality on a log sodium scale. Most of the parameters in (2) are
not identified due to the fact that Z1 is completely unobserved. To help identify the condi-
tional distributions in (2), we make the first-order Markov assumption that f(Z1|Y1, Z0, Y0,X) =
f(Z1 | Y1, Z0,X) such that the conditional distribution of Z at time 1 (6-months) de-
pends only on its version measured with error and its previous (baseline) measurement.
For f(Z0 | Y1, Y0,X) we make the similar assumption that f(Z0 | Y1, Y0,X) = f(Z0 | Y0,X).
These conditional independence assumptions cannot be checked in our data. Equation (2)
reduces to:
f(Z1, Z0, Y1, Y0 |X) = f(Z1 | Y1, Z0,X)f(Z0 | Y0,X)f(Y1, Y0 |X), (3)
where, under our multivariate normality assumption, the conditional distributions in (3) are
a sequence of linear regression models. Only the parameters associated with f(Y1, Y0 |X) on
the right-hand-side of (3) are identified. The parameters from the conditional distributions
of Z1 and Z0 are not identified.









8 Biometrics, 000 0000
In the following subsections, we describe our strategies for identification of the unidentified
parameters in f(Z1 | Y1, Z0,X) and f(Z0 | Y0,X) on the right-hand side of (3).
4.1 Identification of f(Z0 | Y0,X)
Identification of the conditional distribution of Z given Y and X at baseline in PREMIER
is based on the transportability assumption that f(Z0 | Y0,X, S = `) = f(Z0 | Y0,X, S = v).
However, urinary sodium, while considered unbiased, is subject to classical measurement
error (Prentice et al. 2002). Therefore, to estimate f(Z0|Y0,X, S = v) in OPEN, we must first
correct for measurement error in urinary sodium intake in order to estimate the distribution
of “true” sodium intake conditional on self-reported sodium intake. We do this using the
replicate measures of urinary sodium in OPEN to partition the conditional variance of urinary
sodium into its between-subject and within-subject components. The within-subject variance
is considered measurement error and is removed (Willet 2013, chap. 12), resulting in error-
corrected urinary sodium intake.
Let W0r, r = 1, 2 represent the two replicate values of urinary sodium that were obtained
from OPEN participants around the time of the 24-hour recall (Y0). We assume W0r = Z0+er
where the er are independent with mean 0 and common variance and independent of X and
Y0. Then E(W0r | Y0,X) = E(Z0 | Y0,X) and Cov(W01,W02 | Y0,X) = V ar(Z0 | Y0,X). We







2,Z0·Y0XXi + b0i + εir (4)
where b0i ∼ N(0, σ2(v)Z0·Y0X) and εir ∼ N(0, σ
2
w).
The distribution f(Z0 | Y0,X) in OPEN is







where the parameters in (5) are obtained from fitting model (4).
The distribution of f(Z0 |Y0,X, S = `) in the intervention study is specified as the following
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linear regression model:







To identify the parameters in (6), we make the transportability assumption that the


















In Section 4.2 we use the parameters in (7) to help identify the conditional distribution of
Z1 in (3). For the rest of this manuscript we omit the superscript ` on all parameters and
assume they are associated with PREMIER.
4.2 Identification of f(Z1 | Y1, Z0,X)
Identification of the parameters in f(Z1 | Y1, Z0,X) is problematic because Z1 is completely
unobserved in both PREMIER and OPEN. Thus, we need to make several assumptions
regarding the joint relationship of Z1, Y1, and Z0 conditional on X. The first assump-
tion is that the calibration model is time and treatment invariant (Definition 3), that is,
f(Z1 |Y1,X, S = `) = f(Z0 |Y0,X, S = `). This assumption results in the following parameter
restrictions:





For f(Z1 | Y1, Z0,X); there are two sets of unidentified parameters: the partial correlation
between Y1 and Z0 given X and the partial correlation between Z1 and Z0 given Y1 and X.
Both of these parameters are unrestricted and independently range from -1 to 1 (Daniels and
Pourahmadi 2009). To identify these parameters we make assumptions which we incorporate
into our model using informative prior distributions. First, we assume 0 < corr(Y1, Z0 |X) <
corr(Y0, Z0 |X) such that the partial correlation between self-reported sodium at time 1 and
true sodium intake at baseline is positive and less than the partial correlation of these two
variables at baseline. The correlation of Y0 and Z0 given X is given in Web Appendix C. Based









10 Biometrics, 000 0000
on this assumption, a non-degenerate prior distribution for corr(Y1, Z0|X) is corr(Y1, Z0|X) ∼
Uniform{0, corr(Y0, Z0 |X)}.
The second unidentified parameter in f(Z1 | Y1, Z0,X) is the partial correlation of Z1
and Z0 given Y1 and X. Positing this quantity directly is difficult, so we instead posit the
partial correlation of Z1 and Z0 given X while taking into account that this correlation




Z0Y1·X). We assume corr(Z1, Z0 | X) =
corr(Y1, Y0 |X) + ∆Zρ such that the partial correlation between two adjacent measurement
error corrected variables is centered around the partial correlation between two adjacent
self-reported measurements. The parameter ∆Zρ can be viewed as an error term and has the
prior distribution ∆Zρ ∼ Uniform(−δ, δ).
Combining our assumption regarding the partial correlation of Z1 and Z0 with its boundary




























After obtaining corr(Y1, Z0 |X) and corr(Z1, Z0 | Y1,X), we obtain f(Z1 | Y1, Z0,X) using
f(Z1 | Y1, Z0,X) =
f(Z1, Z0 | Y1,X)
f(Z0 | Y1,X)
.
Parameter estimators for the regression of Z0 on Y1 and X are given in Web Appendix C.
The regression of Z1 on Y1, Z0, and X can be written as
Z1 ∼ N(β0,Z1·Y1Z0X + β1,Z1·Y1Z0XY1 + β2,Z1·Y1Z0XZ0 + β3,Z1·Y1Z0XX, σ2Z1·Y1Z0X). (10)
Estimators for the parameters of this regression are also given in Web Appendix C.









Measurement error correction and sensitivity analysis 11
4.3 Estimation
Parameter draws from the posterior distribution of f(Y1, Y0 |X)—as well as imputations of
missing values of Y1 and Y0 were obtained using Markov Chain Monte Carlo (MCMC) via
a Bayesian multivariate normal model implemented in the R package norm2 (Schafer 2016).
We used an improper Jeffreys’ prior for the covariance matrix and the mean parameters.
Estimation of the model parameters in (4) also used MCMC based on the Bayesian linear
mixed-effects approach implemented in the R package pan (Zhao and Schafer 2016). We used







and gamma priors with shape and scale parameters equal to 0.5 for the random effects and
error precision parameters.
In both models, after a 10,000 iteration burn-in period, we performed an additional 50,000
iterations and obtained 100 imputations for each missing value of Y1 and Y0 and 100 param-
eter values by selecting every 500th iteration. We assessed convergence of our Markov chains
by visual inspection of trace plots and autocorrelation plots.
5. Sensitivity Analyses
We investigate how sensitive the effects of the PREMIER intervention are to changes in
measurement error over time and between treatment conditions. A longitudinal study may 1)
result in more accurate/precise reports of diet due to improved self-monitoring; 2) encourage
participants to misreport their diet in order to appear compliant with the intervention;
and/or 3) result in no change in the measurement error seen at baseline.
Sensitivity analyses are anchored at calibration model invariance with respect to treatment
and time (Definition 3 in Section 3) which is represented by the parameter constraints
in (8). Our sensitivity analyses are based on exploring departures from these constraints and
their results on our inferences. For interpretability, we consider sensitivity to the assumption
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that the intercept of the regression of Z on Y and X at baseline is the same at follow-up
(β0,Z1·Y1X = β0,Z0·Y0X). We also consider sensitivity to the assumption that the slope between
Z and Y is the same at baseline as at follow-up (β1,Z1·Y1X = β1,Z0·Y0X).
5.1 Intercept sensitivity parameter
Departures from calibration model invariance with respect to treatment and time in terms






; where the sensitivity parameter ∆
(d)
β0
measures the additional under or over
reporting at month 6 (t = 1) as compared to baseline for a given level of self-report. The
superscripts correspond to the treatment group (d=1) or control group (d=0).
We scale ∆β0 in terms of a percent increase or decrease in the residual standard deviation
σZ0·Y0X in (7). For example, when ∆β0 = 1.2× σZ0·Y0X, the intercept of the regression of Z1
on Y1 and X is 20% of a residual standard deviation greater than the intercept of Z0 on Y0
and X. This sensitivity parameter can be both greater and less than 1 so that the amount
of underreporting can both increase or decrease.
5.2 Slope sensitivity parameter
In PREMIER, participants in both the Established and the Established Plus DASH con-
ditions were counseled to reduce sodium intake to less than 2300 mg/day. We center the
regression line at baseline around this intervention target value of sodium intake and then




0,Z1·Y1X = β0,Z0·Y0X + (1−∆
(d)
β1











> 1, participants who fail to meet (i.e. exceed) the target value self-
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report less—for a given level of true intake—than they did at baseline. And participants who
did achieve the target value self-report more—for a given level of true intake—than they did
at baseline. The degree of deviation from baseline is based on how far the participant deviates




have the effect of increasing the mean of Z1 and values of ∆
(d)
β1
< 1 decrease the mean of
Z1 as compared to a time-invariant calibration model (∆
(d)
β1
= 1). See Web Appendix D for
details.
6. Application to the PREMIER study
6.1 Imputation and analyses
We used the nested imputation approach and associated combining rules of Reiter (2008)
for settings where data are used for imputation but not analysis. Specifically, we obtain 100
parameter draws and generate 20 imputations for each parameter draw resulting in 2000
imputations for each value of Z.
Using imputed values of sodium intake measured without error drawn from Models (6)
and (10) where X represents log BMI and sex, we estimated the difference in reduction
of sodium intake between treatment conditions as in (1). We report the effect size of the
intervention (the treatment difference scaled by its pooled standard deviation) and the p-













). We examine the effect













to range in 10% increments from -50% to 50% of the residual standard






range from 1/3 to 3. Finally, we
set the δ parameter in (9) equal to 0.2 throughout all our analyses so that corr(Z1, Z0 |X)
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ranges uniformly between corr(Y1, Y0 |X)±0.2 (subject to the positive definiteness restriction
in (9)).
6.2 Results
Figures 1(a) and 1(b) are contour plots of the results of our sensitivity analyses of the effect of
the PREMIER intervention at month 6 based on varying the intercept sensitivity parameters
described in Section 5.1. Slope sensitivity parameters in Figures 1(a) and 1(b) are fixed across




, the sensitivity parameter for the treatment group intercept term. The
y-axis displays values for the multiplier of ∆
(0)
β0
, the sensitivity parameter for the control
group intercept term. The solid dot represents calibration model invariance with respect to










The top panel (Figure 1(a)) displays effect sizes and the bottom panel (Figure 1(b)) their
associated p-values.
[Figure 1 about here.]
Under calibration model invariance with respect to treatment and time, the effect size (ES)
is -0.11, a small effect favoring the tre tment condition (p=.004). This effect size remains













β that drives the treatment effect,
not the individual values themselves (see Web Appendix D for details). However, inferences
are very sensitive to departures from calibration model invariance with respect to treatment.
The top left quadrant of Figures 1(a) and 1(b) is the scenario where participants in the
treatment condition under-report less at follow-up than they did at baseline while those in
the control condition under-report more at follow-up. Here, effect sizes are very large (ES=-
1.0), and significant (p<.001). The opposite scenario—treatment participants under-report
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more, control participants under-report less—is displayed in the bottom right portion of
Figures 1(a) and 1(b). Here, the intervention now favors the control group. More modest
assumptions are reflected in between these two extremes.
[Figure 2 about here.]
Figures 2(a) and 2(b) are contour plots of effect sizes and p-values based on varying the
slope sensitivity parameters described in Section 5.2. Intercept sensitivity parameters in








, the sensitivity parameter for the control group intercept term. The solid dot







Departures from time invariance occur when ∆
(d)
β1
6= 1. As mentioned in Section 5.2, when




> 1 have the effect of increasing the mean of Z1 and values of ∆
(d)
β1
< 1 decrease the
mean of Z1. In the treatment condition, where the 6-month sodium value is less than the
target value, values of ∆
(d)
β1
have the opposite effect. As a result, effect sizes in Figure 2(a)
are largest and smallest in the upper right and lower left quadrants, respectively (see Web
Appendix D for details). In general, the slope sensitivity parameters have less of an impact
on the treatment effect as compared to the intercept sensitivity parameters. The p-values of
the treatment effects displayed in Figure 2(b) are significant across all values of the slope
sensitivity parameters. Tabulations of point estimates, treatment differences, 95% confidence
intervals, as well as effect sizes and p-values from the sensitivity analyses in Figures 1 and 2
are reported in Web Appendix E.
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7. Evaluation using internal biomarker data
A unique aspect to the PREMIER study was that 24-hour urine samples were obtained on
all participants both at baseline and at follow-up. Figure 3 displays a forest plot of effect
sizes and their associated 95% confidence intervals for observed 24-hour urinary sodium (top
row), self-reported sodium, and a range of measurement error-corrected analyses based on
different sensitivity parameters. Analyses have been sorted based on how far they deviate
from the 24-hour urine results (vertical dotted line).
[Figure 3 about here.]
Measurement error corrections that are based on calibration model invariance with respect to
treatment and time (or mild departures from it) provide results similar to the 24-hour urine
analysis. Sensitivity analyses that assume treatment group participants under-report less at
follow-up as compared to baseline provide results in line with self-reported sodium values.
Note that measurement error corrected analyses are more precise than those analyses based
on observed urinary sodium values due to the fact that the measurement error corrected
analyses are based on “true” sodium intake after removing within-subject variability as
described in Section 4.1.
8. Discussion
After correcting for measurement error, effect sizes in PREMIER were smaller than effect
sizes based on using self-reported sodium but still significant. Treatment effects were sensitive
to modest assumptions regarding shifts in the intercept of the calibration model. An assump-
tion that treatment participants underreported 20% more of a standard deviation at follow-
up as compared to baseline—and control participants had no change in underreporting—
resulted in an effect size close to 0 that was no longer significant. This sensitivity is partly
due to the fact that the measurement error corrected effect size (under calibration model
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invariance with respect to treatment and time) was small initially. Thus modest assumptions
that result in a shrinking of this already small treatment effect can result in a non-significant
finding. In other applications with larger effect sizes, the treatment effect may be more robust
to these assumptions.
Our sensitivity analyses also included more extreme assumptions which resulted in infer-
ences favoring the control group. As in any sensitivity analysis, the analyst must consider
which assumptions are plausible based on evidence from previous studies and which are not.
For example, in some settings one might consider it unrealistic that control participants
would under-report more at follow-up than at baseline. This assumption would restrict
the sensitivity analyses to the bottom halves of the plots in Figures 1(a) and 1(b), thus
narrowing the range of inferences. Alternatively, the analyst could draw treatment and
control sensitivity parameters from a joint prior where the two sensitivity parameters are
correlated (Linero and Daniels 2015).
We only dealt with two time points and as the number of time points increases, so does
the number of unidentified parameters. This is a also a concern in longitudinal studies with
nonignorable drop-out (Daniels and Hogan 2008) and an area of future work is to build
on approaches from the longitudinal missing data literature for reducing the dimension of
nonidentifed parameters and adapt them to measurement error correction.
The fact that our measurement-error corrected inferences were similar to inferences that
used urinary sodium values in PREMIER suggests that our methods are appropriately reduc-
ing measurement error. However, a more thorough evaluation is necessary to further validate
our approach. In Web Appendix F we give the results of a simulation study that examines
the performance of our method under a range of invariant and varying calibration model
scenarios using both fixed values (point-mass priors) and proper priors for the sensitivity
parameters in order to propagate the uncertainty of the sensitivity parameters. We obtained
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low bias and good coverage when the calibration model was correctly specified and the use of
non-degenerate priors improved coverage when the true calibration model was misspecified.
Throughout the paper we assumed transportability of the calibration model. This is a
critical assumption and analysts should think carefully before transporting the results from
an external validation study. Our model conditions on baseline demographics which may
make the transportability assumption more feasible but the transportability assumption
deserves a sensitivity analysis of its own and the methods described in Section 5 could be
used to assess the sensitivity of inferences to violations of the transportability assumption.
We take a missing data approach to measurement error correction where the unknown true
quantities are treated as unobserved. To do this, we model the joint distribution of Y and Z
in the trial as f(Z, Y ) = f(Z | Y )f(Y ). Here, the identified and unidentified parameters of
the joint distribution are transparent and easy to posit. Many measurement error methods
begin by specifying the measurement error model as f(Y |Z). Modeling the joint distribution
as f(Z, Y ) = f(Y | Z)f(Z) is more difficult because the unidentified parameters of these
distributions are both unidentified and restricted by the observed marginal distribution of
Y . In addition, the validation study provides us with no information regarding the marginal
distribution of Z in the trial.
A limitation of our work is that recovery biomarkers do not exist for many relevant
outcomes in dietary intervention studies. Work is ongoing to widen the class of unbiased
biomarkers (Hedrick et al. 2012). Further, we are interested in extending our current work
using concentration biomarkers which are biomarkers that are correlated with dietary in-
take (many of which are targets of interventions) but, unlike recovery biomarkers, are not
unbiased. Here, feeding studies that measure both true intake and concentration biomarkers
could be used as external validation studies for measurement error correction.
We made other assumptions regarding conditional independence and associations between
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unobserved variables that were not subject to sensitivity analysis. In order to make the
results from our sensitivity analyses manageable and interpretable, it was necessary to focus
on those assumptions in our analyses which we felt were the least plausible and at the same
time would have the most influence on our inferences. This is true of any sensitivity analysis
and an advantage of the Bayesian approach investigated here is that sensitivity analyses for
other parameters can easily be incorporated into our imputation models through the use of
informative priors.
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Figure 1: Contour plot for (a) effect sizes at 6-months and (b) their associated p-values from
an analysis of the PREMIER data across a range of sensitivity parameters for the intercept
of the measurement error model at follow-up as compared to baseline. The x-axis displays
values for the sensitivity parameter for the treatment group, the y-axis displays values for
the sensitivity parameter for the control group. The point plotted at (0, 0) corresponds to
an assumption of calibration model invariance with respect to treatment and time. A color
version of this Figure can be found in the electronic version of this article.
























































































Figure 2: Contour plot for (a) effect sizes at 6-months and (b) their associated p-values
from an analysis of the PREMIER data across a range of sensitivity parameters for the slope
of the measurement error model at follow-up as compared to baseline. The x-axis displays
values for the sensitivity parameter for the treatment group, the y-axis displays values for
the sensitivity parameter for the control group. The point plotted at (1, 1) corresponds to
an assumption of calibration model invariance with respect to treatment and time. A color
version of this Figure can be found in the electronic version of this article.
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Figure 3: Forest plot of effect sizes and their associated 95% confidence intervals for observed
24-hour urinary sodium (top row), self-reported sodium, and a range of measurement error-
corrected analyses based on different sensitivity parameters. The terms “Greater” and “Less”
refer to whether—for a given value of self-report—true intake at follow-up is greater or less
than true intake at baseline, respectively. Analyses have been sorted based on how far they
deviate from the 24-hour urine results (vertical dotted line). Measurement error corrections
that are based on calibration model invariance with respect to treatment and time (or mild
departures from it) provide results similar to the 24-hour urine analysis. Sensitivity analyses
that assume treatment group participants under-report less at follow-up as compared to
baseline provide results in line with self-reported sodium values. Note that measurement
error corrected analyses are more precise than analyses based on observed values due to the
fact that the measurement error corrected analyses are based on “true” sodium intake after
removing within-subject variability.
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Table 1: Demographic characteristics and baseline sodium intake in PREMIER and OPEN
by gender. Values are mean (SD) unless otherwise noted. Three PREMIER participants
were missing self-reported sodium intake at all three time points and were not included
in our analysis. Ten PREMIER and 25 OPEN participants were excluded due to extreme
self-reported total energy intake values.
PREMIER OPEN
Variable (n=797) (n=459)
Male, n (%) 303 (38) 244 (53)
Age 50.0 (8.9) 53.7 (8.3)
BMI 33.0 (5.7) 27.7 (5.1)
(Log) Self-reported sodium 8.0 (0.41) 8.2 (0.43)
(Log) Urinary sodium 8.4 (0.44) 8.4 (0.45)
Note. PREMIER age values are from (Svetkey et al. 2003) and include the entire sample
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Table 2: Patterns of missing data in the PREMIER and OPEN studies. The variables Y0
and Y1 represent self-reported sodium intake via 24-hour recall measured at baseline, and 6-
months, respectively. The variables Z0 and Z1 are versions of Y measured without error. The
variables W01 and W02 are replicate urinary sodium values taken at baseline in OPEN and are
considered unbiased measures of Z0. The variables X and D represents background covariates
and treatment condition, respectively. OPEN participants are assumed to all belong to the
control condition. Grey cells indicate observed values, white cells indicate missing values.
Note that all values are missing for Z0 and Z1 in both studies.
Data
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